Three Ways to Slow Down Type 2 Diabetes-Related Brain Aging

Translate to Spanish or other 102 languages!

Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain.  Image for illustration purposes
Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain. Image for illustration purposes
- Advertisement -

Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain. Researchers have also discovered evidence of diabetes leading to faster brain aging, which could increase the risk of Alzheimer’s. But is there a way to prevent this, and how so? In this podcast, we discuss lifestyle interventions that could help slow diabetes-related cognitive decline.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/3-lifestyle-changes-slow-down-type-2-diabetes-related-brain-aging?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-10-10&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f#1

- Advertisement -

Information Source:  https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Larger Families Associated With Reduced Stroke Risk, New UT Health San Antonio Research Shows

Research co-led by UT Health San Antonio, the academic health center of The University of Texas at San Antonio, associates a greater number of live births with a reduced risk of stroke or brain damage for mothers.

Despite a Cure, Millions Remain Untreated for Hepatitis C

Mega Doctor News by University of Virginia Newswise — CHARLOTTESVILLE, Va. – Millions of Americans...

Updated Guidance Seeks to Reduce Risks From Pulmonary Embolism

Mega Doctor News American Heart Association Clark was 32 in the fall of...

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).
- Advertisement -